Supporting COVID-19 School Safety for Children With Disabilities and Medical Complexity.
Supporting COVID-19 School Safety for Children With Disabilities and Medical Complexity.
复制标题
DOI：
10.1542/peds.2021-054268h
复制
发表时间：
2022-02-01
期刊：
影响因子：
8
通讯作者：
Gurnett CA
中科院分区：
文献类型：
--
作者：
Sherby MR;Kalb LG;Coller RJ;DeMuri GP;Butteris S;Foxe JJ;Zand MS;Freedman EG;Dewhurst S;Newland JG;Gurnett CA
患有智力和发育障碍（IDD）的儿童和患有医疗复杂性（CMC）的儿童受到COVID-19大流行的不成比例的影响，包括学校关闭。患有IDD和CMC的儿童依赖学校满足大量的教育、治疗、医疗和社会需求。然而，在COVID-19大流行期间，为患有IDD和CMC的儿童维持安全的学校可能很困难，因为在这种高风险环境中实施预防战略面临独特挑战，例如戴口罩、保持社交距离和保持手部卫生。此外，缺碘症和CMC患儿出现感染并发症和死亡的风险较高，因此需要制定有效的缓解战略。本报告的目的是描述在这一高危人群中实施几种严重急性呼吸综合征冠状病毒2 （SARS-CoV-2）筛查检测模型。通过描述这些模型，我们希望确定可推广和可扩展的方法，以便在当前和未来的大流行期间为患有IDD和CMC的儿童提供安全的学校运营。本报告描述了COVID-19大流行期间智力和发育障碍儿童和医疗复杂性儿童学校的SARS-CoV-2监测测试模型。
Children with intellectual and developmental disabilities (IDD) and children with medical complexity (CMC) have been disproportionally impacted by the COVID-19 pandemic, including school closures. Children with IDD and CMC rely on schools for a vast array of educational, therapeutic, medical, and social needs. However, maintaining safe schools for children with IDD and CMC during the COVID-19 pandemic may be difficult due to the unique challenges of implementing prevention strategies, such as masking, social distancing, and hand hygiene in this high-risk environment. Furthermore, children with IDD and CMC are at a higher risk of infectious complications and mortality, underscoring the need for effective mitigation strategies. The goal of this report is to describe the implementation of several screening testing models for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in this high-risk population. By describing these models, we hope to identify generalizable and scalable approaches to facilitate safe school operations for children with IDD and CMC during the current and future pandemics. This report describes SARS-CoV-2 surveillance testing models for schools of children with intellectual and developmental disabilities and medical complexity during the COVID-19 pandemic.